Medelis is a specialty oncology CRO focused on preclinical and phase 1 through phase 3 oncology trials in North America and Europe. Founded in 2003, Medelis provides sponsors with oncology expertise from drug development thought-leadership to a highly skilled clinical operations team, handling complex oncology trials in all indications, including cutting-edge immunotherapy treatments.
View Top Employees from Medelis, Inc.Website | http://www.medelis.com/ |
Revenue | $25 million |
Employees | 33 (33 on RocketReach) |
Founded | 2003 |
Address | 30 Burton Hills Blvd Ste 500, Nashville, Tennessee 37215, US |
Phone | (615) 297-6105 |
Fax | (615) 385-7055 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Bioinformatics, Oncology CRO Services, Retail, Biotechnology, Oncology Drug Development Consulting, Data and Analytics, Design and Management of Immuno-Oncology Studies, Science and Engineering, Study Design, Pharmaceutical, Study Launch, Health Care, Study Management, Medical Writing, Data Management and Biostatistics, Clinical Trials Regulatory and QA |
Web Rank | 10 Million |
Keywords | Tumor Immunity Stimulation Vs. Inhibition, Phase 1b Trial Definition, Big Cro In Tornoto, Contract Research Organizations Cancer |
Competitors | CR2O | Clinical CRO, Concentrics Research, an IQVIA business, Pharmatech, Quality Data Services, Inc., Theradex Oncology |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Medelis, Inc. employee's phone or email?
The Medelis, Inc. annual revenue was $25 million in 2024.
Brad Phillips is the Vice President of Clinical Operations of Medelis, Inc..
33 people are employed at Medelis, Inc..
Medelis, Inc. is based in Nashville, Tennessee.
The NAICS codes for Medelis, Inc. are [541, 54, 5417].
The SIC codes for Medelis, Inc. are [873, 87].